For providers
Pathologists

The full genomic story starts with the sample

Tissue sample preservation is a key parameter to uncovering the full genomic story. OncoExTra® helps ensure tissue samples are used efficiently, providing personalized treatment paths to patients with advanced solid tumor cancers.
A tray of specimen slides being held by a gloved lab technician.

Raising the bar on treatment with biomarker testing

The use of biomarker testing is a growing trend,1 with multi-gene genomic sequencing preferred by major guidelines for patients with advanced solid tumors.2
Over 60%
of oncology medicines launched from 2019 to 2024 in the US require or recommend testing for pharmacogenomic biomarkers3
3 out of 4
oncologists report using next-generation sequencing to help guide treatment decisions4
Over 33%
of US patients with cancer miss out on oncology treatment because of suboptimal testing practices5

Three ways to stay ahead of any testing process barriers

Communicate early and often across your patient’s care team

A pathologist can serve as the centerpiece of communication to help ensure that personalized testing starts at the tissue.

Be part of the initial tumor sampling

Communication with the surgeon during or prior to resection can help ensure that the specimen is of sufficient quantity and quality to help increase diagnostic accuracy.6

Prioritize the most appropriate and comprehensive tests first

Consider comprehensive tests that enable simultaneous testing for multiple approved therapeutic targets or separating samples into individual blocks.2,7-8

A rigorous lab process drives our reliable reporting

Illustration of technician working in a lab.

Uncover more variants with the full genomic story

There are actionable variants that could be missed by fixed-panel tests. The OncoExTra test utilizes whole-exome and whole-transcriptome sequencing across nearly 20,000 genes to deliver more answers for every sample submission.9*
Provider sitting at his desk looking at tablet in his hands with a monitor off to the side.

All-encompassing genomic profiling

Clinically actionable results

Patient-matched tumor-normal sequencing

Actionable variants have been found across various types of solid tumors9

98%
of colorectal samples
(164/167)
96%
of lung samples
(53/55)
96%
of bladder samples
(25/26)
93%
of breast samples
(80/86)

Expedite time to treatment with the OncoExTra test

Learn how through smart testing and tissue processing, the OncoExTra test can help enable more personalized care for your patients, faster.

Pathology guide

Everything Pathologists need to know about getting started with the OncoExTra test.

Specimen requirements

The specimen guidelines for the OncoExTra test enables a seamless experience for patients.

The OncoExTra report

The easy-to-interpret report highlights the most actionable insights for timely decision-making.
Physician working on a laptop in an office setting.

Simple ordering and result tracking. All in one hub.

Quickly place and manage test orders, track results, and access easy-to-interpret reports on the Exact Sciences Provider Hub.

Have questions?

Call us at 1 866-662-6897.